Matarin Capital Management, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 127 filers reported holding PTC THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 4.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$474,514,000
+24.6%
14,0680.0%0.03%
+17.2%
Q1 2018$380,680,000
+37.6%
14,068
-15.2%
0.03%
+31.8%
Q4 2017$276,671,000
-92.6%
16,587
-91.1%
0.02%
-93.1%
Q3 2017$3,743,331,000
+35.6%
187,073
+24.2%
0.32%
+24.7%
Q2 2017$2,760,516,000
+1431.9%
150,601
+722.4%
0.26%
+1316.7%
Q1 2017$180,200,00018,3130.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders